Prophylactic Therapy With Valganciclovir in High-Risk (Cytomegalovirus D+/R−) Kidney Transplant Recipients: A Single-Center Experience
2010 ◽
Vol 42
(8)
◽
pp. 2947-2949
◽
2019 ◽
Vol 19
(3)
◽
pp. 68
2018 ◽
Vol 50
(10)
◽
pp. 3452-3459
◽
2018 ◽
Vol 50
(10)
◽
pp. 3351-3355
◽
2019 ◽
Vol 17
(Suppl 1)
◽
pp. 135-141
2016 ◽
Vol 48
(7)
◽
pp. 2315-2318
◽